» Articles » PMID: 23921815

Bile Acid at Low PH Reduces Squamous Differentiation and Activates EGFR Signaling in Esophageal Squamous Cells in 3-D Culture

Overview
Specialty Gastroenterology
Date 2013 Aug 8
PMID 23921815
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Barrett's esophagus is a preneoplastic metaplasia in which the normal squamous epithelium of the esophagus changes to an intestinal, columnar phenotype due to long-term gastro-esophageal reflux. The major components of this reflux are bile and stomach acid. Previous in vitro studies on the effect of bile and acid on esophageal cells have predominantly relied on transformed esophageal squamous cells or cancer cells grown in monolayer culture.

Discussion: In this study, we expanded our previous work using an immortalized primary esophageal squamous cell line (EPC1). We demonstrate that EPC1 cells form a multi-layer, stratified epithelium when grown on polyester transwell filters in media supplemented with calcium. When exposed to short pulses of bile and pH 5, but not either condition alone, EPC1 cells demonstrate a reduction in stratification layers and reduced expression of squamous epithelium-specific genes. Bile at pH 5 also causes activation of epidermal growth factor receptor and down-stream pathways. Blocking epidermal growth factor receptor activation partially attenuates the effects of bile acid and pH 5. These results suggest that bile at low pH, but not bile or low pH alone, promotes loss of differentiation status of stratified squamous esophageal epithelium in vitro, possibly by initiating a mucosal repair response through epidermal growth factor activation.

Citing Articles

Impact of post RFA treatment on neosquamous epithelium microstructure.

Skrobic O, Simic A, Pesko P, Kravic-Stevovic T, Martinovic T, Bumbasirevic V Sci Rep. 2024; 14(1):28895.

PMID: 39572749 PMC: 11582558. DOI: 10.1038/s41598-024-80081-2.


Roles of Cytokines in Pathological and Physiological Gastroesophageal Reflux Exposure.

Ergun P, Kipcak S, Gunel N, Bor S, Sozmen E J Neurogastroenterol Motil. 2023; 30(3):290-302.

PMID: 37957115 PMC: 11238103. DOI: 10.5056/jnm22186.


The role of bile acid in intestinal metaplasia.

Wang M, Lou E, Xue Z Front Physiol. 2023; 14:1115250.

PMID: 36891144 PMC: 9986488. DOI: 10.3389/fphys.2023.1115250.


HIDA and Seek: Challenges of Scintigraphy to Diagnose Bile Reflux Post-Bariatric Surgery.

Eldredge T, Bills M, Myers J, Bartholomeusz D, Kiroff G, Shenfine J Obes Surg. 2020; 30(5):2038-2045.

PMID: 32133588 DOI: 10.1007/s11695-020-04510-7.


From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.

Gokulan R, Garcia-Buitrago M, Zaika A Biochim Biophys Acta Rev Cancer. 2019; 1872(1):37-48.

PMID: 31152823 PMC: 6692203. DOI: 10.1016/j.bbcan.2019.05.003.


References
1.
Dvorak K, Watts G, Ramsey L, Holubec H, Payne C, Bernstein C . Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma. Am J Gastroenterol. 2009; 104(2):302-9. PMC: 4450811. DOI: 10.1038/ajg.2008.85. View

2.
Modiano N, Gerson L . Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment. Ther Clin Risk Manag. 2008; 3(6):1035-145. PMC: 2387291. View

3.
Tassone F, Hagerman R, Taylor A, Gane L, Godfrey T, Hagerman P . Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet. 2000; 66(1):6-15. PMC: 1288349. DOI: 10.1086/302720. View

4.
Atanassoff P, Brull S, Weiss B, Landefeld K, Alon E, Rohling R . The time course of gastric pH changes induced by omeprazole and ranitidine: a 24-hour dose-response study. Anesth Analg. 1995; 80(5):975-9. DOI: 10.1097/00000539-199505000-00021. View

5.
Feagins L, Zhang H, Zhang X, Hormi-Carver K, Thomas T, Terada L . Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines. Am J Physiol Gastrointest Liver Physiol. 2007; 294(2):G411-7. DOI: 10.1152/ajpgi.00373.2007. View